Literature DB >> 16991121

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

Silvia Franceschi1, Rolando Herrero, Gary M Clifford, Peter J F Snijders, Annie Arslan, Pham Thi Hoang Anh, F Xavier Bosch, Catterina Ferreccio, Nguyen Trong Hieu, Eduardo Lazcano-Ponce, Elena Matos, Monica Molano, You-Lin Qiao, Raj Rajkumar, Guglielmo Ronco, Silvia de Sanjosé, Hai-Rim Shin, Sukhon Sukvirach, Jaiye O Thomas, Chris J L M Meijer, Nubia Muñoz.   

Abstract

An inverse relationship between age and human papillomavirus (HPV) prevalence has been reported in many developed countries, but information on this relationship is scarce in many other parts of the world. We carried out a cross-sectional study of sexually active women from the general population of 15 areas in 4 continents. Similar standardised protocols for women's enrolment, cervical specimen collection and PCR-based assays for HPV testing were used. HPV prevalence in different age groups was compared by study area. 18,498 women aged 15-74 years were included. Age-standardised HPV prevalence varied more than 10-fold between populations, as did the shape of age-specific curves. HPV prevalence peaked below age 25 or 35, and declined with age in Italy, the Netherlands, Spain, Argentina, Korea and in Lampang, Thailand and Ho Chi Minh, Vietnam. This was not the case in Songkla, Thailand nor Hanoi, Vietnam, where HPV prevalence was low in all age groups. In Chile, Colombia and Mexico, a second peak of HPV prevalence was detected among older women. In the poorest study areas in Asia (Shanxi, China and Dindigul, India), and in Nigeria, HPV prevalence was high across all age groups. The substantial differences observed in age-specific curves of HPV prevalence between populations may have a variety of explanations. These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences.

Entities:  

Mesh:

Year:  2006        PMID: 16991121     DOI: 10.1002/ijc.22241

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  122 in total

1.  The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.

Authors:  Julia C Gage; Kayode O Ajenifuja; Nicolas A Wentzensen; Akinfolarin C Adepiti; Claire Eklund; Mary Reilly; Martha Hutchinson; Sholom Wacholder; Joe Harford; Amr S Soliman; Robert D Burk; Mark Schiffman
Journal:  Int J Cancer       Date:  2011-08-05       Impact factor: 7.396

2.  Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.

Authors:  Troy J Kemp; Allan Hildesheim; Alfonso García-Piñeres; Marcus C Williams; Gene M Shearer; Ana Cecilia Rodriguez; Mark Schiffman; Robert Burk; Enrique Freer; Jose Bonilla; Rolando Herrero; Ligia A Pinto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

Review 3.  Prophylactic HPV vaccines.

Authors:  Margaret Stanley
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

Review 4.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

Review 5.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

6.  Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.

Authors:  Alison S Rustagi; Aruna Kamineni; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2013-08-21       Impact factor: 4.897

7.  Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.

Authors:  Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

Review 8.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

Review 9.  The immune system in menopause: pros and cons of hormone therapy.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-13       Impact factor: 4.292

10.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.